1.
Case Rep Oncol
; 16(1): 728-733, 2023.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37900826
RESUMO
Pembrolizumab is one of the approved treatments for many types of cancer including clear cell renal cell carcinoma (ccRCC). It has improved the prognosis of renal cell carcinoma, yet has many possible immune-related side effects. We discuss a rare case of rhabdomyolysis in an ccRCC patient treated with pembrolizumab. The case was complicated with acute kidney injury and severe hypothyroidism, which can be attributed to pembrolizumab.
2.
Clin Case Rep
; 10(10): e6457, 2022 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36254147
RESUMO
Behcet's disease is a systemic autoimmune disorder occasionally associated with otological manifestations, including sensorineural hearing loss. We are reporting a case of Behcet's disease, which was complicated by sensorineural hearing loss and managed successfully with anti-TNF agent Infliximab.